We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+13.24%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$43.9B
AUM Growth
+$2.09B
(+5%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-7.52%
Top 10 Holdings %
Top 10 Hldgs %
15.27%
Holding
715
New
81
Increased
209
Reduced
224
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$254M |
| 2 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$243M |
| 3 |
Tesla
TSLA
|
+$215M |
| 4 |
Parker-Hannifin
PH
|
+$181M |
| 5 |
Trade Desk
TTD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$291M |
| 2 |
Meta Platforms (Facebook)
META
|
+$289M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$193M |
| 4 |
XYZ
Block Inc
XYZ
|
+$173M |
| 5 |
Affirm
AFRM
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 13.4% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Industrials | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
10x Genomics
TXG
$6B
| $12.8M | 0.03% |
85,642
+36,403
| +74% | +$5.58M |
|
402
CryoPort
CYRX
$761M
| $12.7M | 0.03% |
214,901
-2,086
| -1% | -$144K |
|
403
Insulet
PODD
$11.5B
| $12.6M | 0.03% |
47,344
+5,599
| +13% | +$1.62M |
|
404
Quanterix
QTRX
$164M
| $12.6M | 0.03% |
296,492
-540,346
| -65% | -$25.2M |
|
405
Applied Industrial Technologies
AIT
$12.8B
| $12.5M | 0.03% |
121,254
+100
| +0.1% | +$10K |
|
406
Five Below
FIVE
$12B
| $12.2M | 0.03% |
59,195
+1,116
| +2% | +$220K |
|
|
SP
407
DELISTED
SP Plus Corporation
SP
| $11.8M | 0.03% |
418,772
+24,100
| +6% | +$722K |
|
408
Fortive
FTV
$17.9B
| $11.7M | 0.03% |
203,400
-9,074
| -4% | -$513K |
|
|
CTLT
409
DELISTED
CATALENT, INC.
CTLT
| $11.7M | 0.03% |
91,180
+3,994
| +5% | +$513K |
|
410
Sysco
SYY
$40.8B
| $11.6M | 0.03% |
147,187
-1,892,250
| -93% | -$146M |
|
411
Brown-Forman Class B
BF.B
$13.2B
| $11.5M | 0.03% |
157,672
-376,495
| -70% | -$26.8M |
|
412
Rigel Pharmaceuticals
RIGL
$681M
| $11.5M | 0.03% |
433,261
-4,209
| -1% | -$127K |
|
|
USER
413
DELISTED
UserTesting, Inc.
USER
| $11.4M | 0.03% |
+1,352,613
| New | +$12.6M |
|
|
SNBR
414
DELISTED
Sleep Number
SNBR
| $11.3M | 0.03% |
147,011
-4,706
| -3% | -$394K |
|
415
Byline Bancorp
BY
$1.78B
| $11.2M | 0.03% |
+410,059
| New | +$10.8M |
|
416
Idexx Laboratories
IDXX
$44.1B
| $11.2M | 0.03% |
16,989
-195,328
| -92% | -$123M |
|
|
PTVE
417
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $11.1M | 0.03% |
872,886
+7,200
| +0.8% | +$93.8K |
|
418
Ametek
AME
$55.4B
| $11M | 0.03% |
74,971
-3,213
| -4% | -$440K |
|
419
Arteris
AIP
$1.38B
| $11M | 0.03% |
+521,565
| New | +$11.8M |
|
|
JOAN
420
DELISTED
JOANN, Inc. Common Stock
JOAN
| $11M | 0.03% |
1,058,026
+6,600
| +0.6% | +$69K |
|
421
Grid Dynamics Holdings
GDYN
$576M
| $10.9M | 0.02% |
+287,574
| New | +$9.94M |
|
|
DBD
422
DELISTED
Diebold Nixdorf Incorporated
DBD
| $10.6M | 0.02% |
1,168,376
+7,400
| +0.6% | +$68.8K |
|
|
AVID
423
DELISTED
Avid Technology Inc
AVID
| $10.5M | 0.02% |
322,114
-3,117
| -1% | -$97K |
|
424
Pulmonx
LUNG
$68.8M
| $10.3M | 0.02% |
321,663
-3,904
| -1% | -$143K |
|
425
Alamo Group
ALG
$1.94B
| $10.3M | 0.02% |
69,688
+12,500
| +22% | +$1.85M |
|
Similar funds
Lord, Abbett & Co's Q4 2021 Portfolio in Review
As of Q4 2021, Lord, Abbett & Co held 715 positions worth $43.9B, up 5% from $41.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Lord, Abbett & Co withdrew a net $3.3B in Q4 2021, closing 119 positions and reducing 224 holdings. Its most notable exit was Snap, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $257M.
- Lord, Abbett & Co's largest Q4 2021 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 117,267 shares worth $257M.
- Lord, Abbett & Co added most to Pfizer in Q4 2021, an estimated $254M increase.
- Lord, Abbett & Co's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $289M.
- Lord, Abbett & Co fully exited Snap in Q4 2021, selling an estimated $291M.
- Lord, Abbett & Co's ten largest holdings make up 15% of its $43.9B portfolio in Q4 2021.
- Lord, Abbett & Co opened 81 new positions and closed 119 in Q4 2021.
- Lord, Abbett & Co's portfolio value rose 5% quarter-over-quarter to $43.9B.
Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.